Clinical Trials Browser

Phase 2 × OTHER × Efficacy and Safety × Clear all

NCT06383078 2024-04-25

HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer

Phase 2 Not yet recruiting

Efficacy and Safety

NCT03660761 2019-04-16

Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors

Phase 2 Completed

Efficacy and Safety